Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Hyderabad(35)
- Bangalore(3)
- Maharashtra(25)
- New Delhi(4)
- Gujarat(30)
- Mumbai(54)
- Andhra Pradesh(3)
- Karnataka(9)
- Telangana(5)
- Pune(5)
- Vadodara(8)
- Delhi(12)
- Ahmedabad(11)
- Madhya Pradesh(1)
- Uttar Pradesh(7)
- Haryana(3)
- Tamil Nadu(2)
- Nagpur(2)
- Kolkata(1)
- Rajasthan(1)
- Beijing(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- PURE
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Minimum 95%
- Min. 98.0% (GC)
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.96%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.9 %
- 99.87%
- 99.86%
- 99.85%
- 99.82%
- 99.80%
- 99.73%
- 99.72%
- 99.70%
- 99.65%
- 99.64%
- 99.56%
- 99.55%
- 99.53%
- 99.5%
- 99.48%
- 99.42%
- 99.40%
- 99.36%
- 99.30%
- 99.29%
- 99.19%
- 99.18%
- 99.05%
- 99.04%
- 99.00%
- 99% HPLC
- > 99%
- >99%
- 99%
- 99
- 98+
- 98.90%
- 98.86%
- 98.76%
- 98.70%
- 98.60%
- 98.55%
- 98.54%
- 98.5%
- 98.5 %
- 98.30%
- 98.20%
- 98.12%
- 98.00%
- >98%
- 98%
- 97-99%
- 97.81%
- 97.57%
- 97.40%
- 97.01%
- 97.00%
- >97%
- 97%
- 97 %
- 96.80%
- 96.40%
- 96.39%
- 96.31%
- 96.14%
- 96%
- 95.48%
- 95.00%
- 95%
- >95%
- 94.59%
- 94.07%
- 94.00%
- 92.71%
- 92.55%
- >92%
- 90-95%
- 90%
- >90%
- 90 % Above
- 86.50%
- 72.96%
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0Customized pack size availaible
- 0MG TO GRAM
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1g
- 10g
- 25g
- 500g
- 100
- 200
- 25
- 100gm
- 50
- 5g
- 50g
- 100g
- 500gm
- 1kg
- 5kg
- 10kg
- 20KG
- 25kg
- 50kg
- 100kg
- 500kg
- 1000kg
- 1MT
- 1and gm
- 250kgs
- 250250 mg.
-
β-Hydroxy Thyroxine
107849-54-7
-
4-Methylumbelliferone
90-33-5
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
3''-ACETYL-2''-HYDROXY-4-(4-PHENYLBUTOXY)BENZANILIDE
136450-06-1
-
4-HYDROXY-BUT-2-ENOIC ACID
24587-49-3
-
2-hydroxy-5-(methylthio)benzaldehyde
67868-84-2
-
6-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one
179688-52-9
-
(3r,4r)-1-benzyl-4-hydroxy-3-pyrrolidinemethanol
253129-03-2
-
5-Bromo-4-chloro-3-indolyl-beta-D-galactoside
7240-90-6
-
4-Hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonic acid
25251-42-7
Levothyroxine Beta Hydroxy Impurity 107849-54-7
Levothyroxine-β-Hydroxy impurity 107849-54-7
7-Hydroxy-4-methylcoumarin 90-33-5
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
(2E)-4-Hydroxy-2-butenoic acid 24587-49-3
(3R,4R)-1-Benzyl-4-hydroxy-3-pyrrolidinemethanol 253129-03-2
5-Bromo-4-chloro-3-indolyl beta-galactoside 7240-90-6
4-Hydroxy-6-(3-sulfophenylamino)-2-naphthalenesulfonic acid 25251-42-7
3-Amino-5-hydroxy-2,7-naphthalenedisulfonic acid 90-40-4
beta-Nicotinamide mononucleotide 1094-61-7
100mg(MOQ)